Clinical studies recruiting near Changzhou

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen
NA · Changzhou Maternal And Child Health Care Hospital · The First Affiliated Hospital with Nanjing Medical Universit · NCT07050537 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · The First People's Hospital of Changzhou · Pfizer · NCT06758401 Compilation and Preliminary Application of the Active Health Behavior Scale in Patients With Type 2 Diabetes
Phase N/A · The Third Affiliated Hospital of Soochow University（THE FIRS · Yun Ye · NCT07531459 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · Takeda · NCT06671496 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Changzhou Second People's Hospital · Eli Lilly and Company · NCT07483099 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Changzhou Second People's Hospital · Eli Lilly and Company · NCT07415044 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Changzhou No 2 Peoples Hospital · Janssen Research & Development, LLC · NCT07499232 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Investigative Site: 1560005 · Sanofi · NCT06958536 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · The First People's Hospital of Changzhou · Pfizer · NCT07144280 A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma
Phase N/A · Changzhou Second People's Hospital · The First Affiliated Hospital with Nanjing Medical Universit · NCT06497738 China HeadAche DIsorders RegiStry
Phase N/A · Changzhou First People's Hospital · Beijing Tiantan Hospital · NCT05334927 Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
NA · Changzhou NO.2 People&#39;s Hospital · Peking Union Medical College Hospital · NCT05866029 Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters
NA · the Second People's Hospital of Changzhou · Changzhou No.2 People's Hospital · NCT06964867 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo
Phase 3 · The First People's Hospital Of Changzhou · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703 Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial
NA · Changzhou First People's Hospital · The Affiliated Hospital Of Guizhou Medical University · NCT06329635 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · The First People's Hospital of Changzhou · Daiichi Sankyo · NCT06731478 A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Pos
Phase 2 · Changzhou Cancer Hospital · RemeGen Co., Ltd. · NCT06962865 Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease
NA · The First People's Hospital of Changzhou · Suzhou Hengruihongyuan Medical Technology Co. LTD · NCT07068438 A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
Phase N/A · Changzhou No 2 Peoples Hospital · Xian-Janssen Pharmaceutical Ltd. · NCT07302360 A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Phase 3 · Changzhou No 2 Peoples Hospital · Janssen Research & Development, LLC · NCT06663332 Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
Phase 3 · The First People's Hospital of Changzhou · Beijing InnoCare Pharma Tech Co., Ltd. · NCT06842199 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · The First People's Hospital of Changzhou · Eli Lilly and Company · NCT06119581 FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension
NA · Changzhou No.2 People's Hospital · Shanghai Hongdian Medical CO., LTD · NCT05590871 Safety and Efficacy of CAG and PCI Via Distal Transradial Access in Patients With Small Vessels
NA · Changzhou Wujin People's Hospital · Cai gaojun, MD · NCT07410364 Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
Phase N/A · The Third Affiliated Hospital of Soochow University · Nanjing Medical University · NCT04398992 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Changzhou Third People's Hospital · Boehringer Ingelheim · NCT06632457 "Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
Phase N/A · The Third Hospital of Changzhou · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT03097952 A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Act
Phase 3 · Sl0044 20186 · UCB Biopharma SRL · NCT06617325 Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
Phase N/A · Changzhou No.2 People's Hospital · Xi Shan Wang · NCT03349762 A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · Changzhou No 2 Peoples Hospital · Janssen Research & Development, LLC · NCT05552222

Look up another city

Look up another condition